During the same periods, our purchases from Supplier B were RMB66.1 million, RMB265.6 million and RMB312.5 million, respectively, accounting for 20.4%, 37.2% and 49.0% of our total purchases for the corresponding years.
Business · 第 177 页
Due to the material reliance we had on Supplier A and Supplier B given the substantial purchases from them during the Track Record Period, any interruption to the supplies from, or loss of, any of our major foundry suppliers would have negative impacts on our results of operations.
Business · 第 177 页
(i) our foundry service agreement with Supplier A is automatically renewed upon expiration unless either party gives a notice of termination; our latest foundry service agreement with Supplier B has a term of eight years, and we had previously made two successful renewal of our agreement with Supplier B;
In 2023, 2024 and 2025, the aggregate purchase amounts from our five largest suppliers for each year were RMB3,859.4 million, RMB2,355.9 million and RMB3,375.8 million, representing 57.0%, 35.2% and 39.2% of our total purchase amount, respectively.
Summary · 第 4 页
The purchase amounts from our largest supplier in the same years were RMB3,386.9 million, RMB1,963.4 million and RMB2,647.5 million, representing 50.1%, 29.3% and 30.8% of our total purchase amount, respectively.
Business · 第 152 页
As our self-owned NEV production facilities continue to ramp up, we expect to gradually reduce our reliance on Geely Group as a supplier and increase the proportion of production in-house.
In 2023, 2024 and 2025, our procurement from the five largest suppliers in each year during the Track Record Period was RMB519.0 million, RMB598.8 million and RMB1,472.6 million, respectively, accounting for 44.4%, 47.7% and 50.8% of our total purchase, respectively.
Business · 第 155 页
Our Directors confirm that we had not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or delay in delivery of our orders from our suppliers during the Track Record Period.
In 2023, 2024 and 2025, cost attributable to our top five largest suppliers in aggregate amounted to Rp1,099,889 million, Rp1,217,985 million and Rp1,780,058 million, respectively, accounting for 59.0%, 64.3% and 72.1% of our total purchase, respectively.
Business · 第 154 页
Such supplier concentration is primarily attributable to advertising, talent and other matter relating to content production purposes.
Business · 第 160 页
Purchases from our top five suppliers were higher in 2025 compared to 2024, primarily due to a higher volume and scale of content production projects undertaken during the period.
Purchases from the five largest suppliers in each year during the Track Record Period accounted for approximately 23.2%, 21.8% and 26.0% of our total purchases for the respective year.
Summary · 第 7 页
We source different raw materials from multiple suppliers in mitigating the risk of single supplier reliance and ensuring the timely delivery of our products.
In 2023, 2024 and 2025, our purchase from our five largest suppliers in each year during the Track Record Period amounted to RMB8,462.3 million, RMB11,891.6 million and RMB11,924.0 million, which accounted for 16.8%, 22.0% and 25.1%, respectively, of our total purchases in the respective year.
Business · 第 198 页
To the best of our knowledge, each of our five largest suppliers in each year during the Track Record Period was an Independent Third Party.
Business · 第 201 页
To the best of our knowledge, none of our Directors, their close associates or any Shareholders of our Company, who or which to the knowledge of the Directors owned more than 5% of our Company’s issued share capital, had any interest in any of our five largest suppliers in each year during the Track Record Period.
北京天星医疗股份有限公司STAR SPORTS MEDICINE CO., LTD.01609.HK
2024年最大供应商采购占比达24.1%
Purchase from our five largest suppliers in each year of 2023, 2024 and 2025 was RMB38.2 million, RMB96.8 million and RMB44.5 million, respectively, accounting for 28.4%, 44.8% and 25.2% of our total purchases for the same year, respectively.
Business · 第 137 页
During the Track Record Period, we purchased UHMWPE through Supplier C.
Business · 第 136 页
In the event we face supply chain disruption, we are capable of sourcing UHMWPE from domestic suppliers at comparable quality and sufficient quantity.
Purchase from our top five suppliers accounted for 51.5%, 44.8% and 44.2% of our total purchases in 2023, 2024 and 2025, respectively, and purchase from our largest supplier accounted for 35.7%, 26.6% and 24.3% of our total purchases in the same periods, respectively.
Summary · 第 5 页
under which we purchased operational support services from Supplier A, including order fulfillment, storage, and customer services, among others. In general, we are required to pay a commission to Supplier A, which is typically a certain percentage rate of our sales revenue generated through our online stores on the same E-commerce marketplace.
In each year during the Track Record Period, our purchases from our five largest suppliers accounted for 39.4%, 38.9% and 38.1% of our total purchases in 2023, 2024 and 2025, respectively.
Business · 第 94 页
Our purchases during the Track Record Period from our largest supplier accounted for 14.1%, 12.7% and 12.1% of our total purchases, respectively, for the same periods.
Business · 第 94 页
During the Track Record Period and up to the Latest Practicable Date, we did not experience any significant fluctuation in prices set by our suppliers, material breach of contracts on the part of our suppliers or delay in delivery of our orders from our suppliers, nor did we have any material disputes with our suppliers.
In 2023, 2024, and 2025, purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB15.1 million, RMB31.5 million, and RMB53.8 million, respectively, accounting for 27.6%, 54.8% and 52.9% of our total purchases for each of the same periods.
Summary · 第 3 页
In addition, we generally source from no more than five suppliers for each type of raw materials.
Business · 第 131 页
During the Track Record Period and up to the Latest Practicable Date, we did not experience quality issues with our suppliers that materially affected our operations and there was no material disruption to the manufacturing of our products due to supply shortage.
During the Track Record Period, purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB1,042.5 million, RMB1,250.9 million and RMB1,331.8 million, representing 41.4%, 47.3% and 37.6% of total procurement for the respective periods.
Business · 第 121 页
Our five largest suppliers in each year during the Track Record Period contributed 41.4%, 47.3% and 37.6% of total procurement for the respective periods.
Summary · 第 3 页
During the Track Record Period, we procured channel traffic services from Supplier A, which served as a user traffic entry point in its capacity as an Aggregation Platform.
北京圆心科技集团股份有限公司Beijing Yuanxin Technology Group Co., Ltd.
前五大供应商采购占比上升
Our top five suppliers in the aggregate accounted for 40.4%, 43.3% and 53.7% of our total purchase amount in 2023, 2024 and 2025, respectively. Our largest supplier accounted for 12.5%, 14.1% and 18.4% of our total purchase amount in 2023, 2024 and 2025, respectively.
Business · 第 143 页
Our centralized purchasing enables us to leverage the national purchasing power of our operations, reduces our dependence on any one supplier and gives us a strong bargaining position to lower costs.
Business · 第 114 页
We believe we have sufficient alternative suppliers for pharmaceutical and healthcare products that can provide us with substitutes of comparable quality and prices.
For the same periods, purchases from our largest supplier in each period during the Track Record Period (namely Supplier A) accounted for 54.8%, 48.7% and 65.2%, respectively, of our total procurement amount for the respective periods.
Summary · 第 6 页
For the years ended December 31, 2023, 2024 and 2025, purchases from our top five suppliers in each period during the Track Record Period amounted to RMB4,116.4 million, RMB5,426.1 million and RMB6,926.8 million, respectively, representing 67.3%, 65.6% and 75.9%, respectively, of our total purchase amount for the respective periods.
Business · 第 144 页
Our Directors are of the view that the business ties between Supplier A and us are bilateral and our businesses are sustainable despite such supplier concentration after taking into account the following factors:
The aggregate purchases from our top five suppliers during each year of the Track Record Period amounted to RMB1,968.9 million, RMB2,265.6 million and RMB2,102.6 million, which accounted for 74.1%, 66.3% and 53.7% of aggregate purchases for, respectively, the aforementioned periods.
Summary · 第 3 页
Purchases from our largest supplier during each year of the Track Record Period were RMB662.0 million, RMB855.6 million and RMB734.0 million, respectively, representing 24.9%, 25.0% and 18.7% of our total purchases, respectively.
Business · 第 144 页
Our Directors confirmed that, During the Track Record Period, we have not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or material delay in delivery of our orders from our suppliers.
We conducted all payments and settlements to such physicians or nurses exclusively through these settlement services partners and did not engage in any direct payment transactions with them.
Business · 第 164 页
During the Track Record Period, our suppliers primarily included our settlement services partners, through whom we deployed physicians and nurses from hospitals to provide medical services in our whole-course healthcare management services, healthcare product suppliers, medical services providers, human resource services providers and insurance agents.
Business · 第 164 页
The agreements typically have a term of one to two years, subject to automatic one-year renewals unless prior written notice of non-renewal is provided.
In 2023, 2024 and 2025, our five largest suppliers for each year of the Track Record Period in aggregate accounted for 40.4%, 50.9% and 65.7% of our total purchase amount, respectively.
Summary · 第 5 页
Such concentration was primarily attributable to (i) we adopt a customised development model and strictly limit the number of our suppliers, (ii) we adopt a procurement strategy of leveraging economies of scale to achieve cost efficiencies and (iii) certain of our key components, including core photovoltaic modules, can currently only be manufactured by a limited number of qualified suppliers that possess the requisite technical capabilities and production expertise.
Business · 第 139 页
During the Track Record Period and up to the Latest Practicable Date, to the best of our knowledge, none of our Directors, their close associates or any of our shareholders (who owned or, to the knowledge of the Directors, had owned more than 5% of our issued share capital) had any interest in any of our five largest suppliers for each year during the Track Record Period.
our purchases from our largest supplier in each year during the Track Record Period amounted to RMB20.8 million, RMB36.2 million, and RMB77.0 million, representing 17.2%, 14.1% and 19.8% of our total purchases, respectively
Business · 第 171 页
In the optical computing industry, critical materials, equipment and processes are often concentrated among a limited number of suppliers with leading technology and production capacity, according to Frost & Sullivan.
Business · 第 172 页
For critical raw materials, we typically qualify at least two, and in some cases three, suppliers and encourage our R&D team to explore domestic substitution solutions, while managing inventory levels based on actual yield rates and order visibility so as to secure timely delivery and minimise excessive stock.
In 2024 and 2025, our purchases from our five largest suppliers in each year in aggregate amounted to RMB241.5 million and RMB280.6 million, respectively, representing 25.3% and 27.8% of our total corresponding purchases, and our purchases from the largest supplier in each period amounted to RMB84.0 million and RMB94.3 million, accounted for 8.8% and 9.4% of our total corresponding purchases, respectively.
Summary · 第 10 页
In addition, adequate alternative sources for such supplies exist, and we have developed alternative sourcing strategies for these supplies.
Business · 第 211 页
During the Track Record Period, our major suppliers for our R&D primarily consisted of CROs, SMOs and CDMOs and we did not experience any material disputes with our suppliers.
For the years ended December 31, 2023, 2024 and 2025, our purchases from our five largest suppliers amounted to RMB69.1 million, RMB173.2 million and RMB201.5 million, accounted for 31.0%, 36.6% and 29.1% of our total purchases for the respective period, respectively.
Business · 第 130 页
For each category of major raw materials and components, we generally engage more than one qualified supplier to secures supplies.
Business · 第 129 页
To the best of our knowledge, all of our five largest suppliers during the Track Record Period are independent third parties.
Purchases from our five largest suppliers amounted to RMB133.8 million, RMB171.3 million and RMB165.8 million in 2023, 2024 and 2025, respectively, representing 41.8%, 51.2% and 46.6% of our total purchases for the same respective periods.
Business · 第 158 页
Our purchases from the largest supplier represented 24.4%, 33.8% and 31.5% of our total purchases in 2023, 2024 and 2025, respectively.
Business · 第 158 页
Before the Sanction came into effect, we had begun seeking collaboration with domestic sequencing equipment suppliers to reduce our reliance on upstream suppliers and mitigate the risk of raw material price fluctuations.